Trial
NCT02409316
[18F]FES PET/CT in Endocrine Refractory Breast Cancer
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Pennsylvania
Collaborators
—
Condition
Estrogen Receptor Positive Breast Cancer
Intervention
[18F]FES
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-11